Top Tweets for #SpringWorksTx
SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from Phase 3 DeFi Trial of OGSIVEO (nirogacestat) in Adults w/ Desmoid Tumors in Journal of Clinical Oncology #SpringWorksTherapeutics, #SpringWorksTx, #MerckKGaA https://t.co/68W5zIUx1Z
European Commission Grants Conditional Approval of EZMEKLY (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN #SpringWorksTherapeutics, #SpringWorksTx, #SpringWorks, #MerckKGaA, #MRK https://t.co/I5ODXqpLzd
SpringWorks Therapeutics Gets Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN $SWTX, #SpringWorksTherapeutics, #SpringWorksTx, #SpringWorks https://t.co/6OvFLdi73g
Merck KGaA, Darmstadt, Germany to Acquire SpringWorks Therapeutics for $47 Per Share in Cash $SWTX, #SpringWorksTherapeutics, #SpringWorksTx, #SpringWorks, #MerckKGaA, #MRK https://t.co/b8MyZ9S4o8
SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union $SWTX, #SpringWorksTherapeutics, #SpringWorksTx, #SpringWorks https://t.co/0O8Bsg4zsq
FDA Approves Mirdametinib / Gomekli for NF1-PN: Data Overview @FDAOncology @SpringWorksTx
#Mirdametinib #NF1PN #SpringWorksTx #Gomekli #Neurofibromatosis #CancerResearch #Oncology #ClinicalTrials #FDAApproval #MEKInhibitor
SpringWorks Therapeutics: FDA OKs GOMEKLI (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN $SWTX, #SpringWorksTherapeutics, #SpringWorksTx, #SpringWorks https://t.co/znpcKSLfEZ
SpringWorks Therapeutics: Data from pivotal Phase 2b ReNeu trial show that patients with NF1-PN achieved deep responses and improvements in health-related quality of life over the course of mirdametinib treatment $SWTX, #SpringWorksTx, #SpringWorks https://t.co/tpCvzh4ZYg
SpringWorks Therapeutics Reveals Phase 2b ReNeu Trial Data: Mirdametinib treatment showed significant confirmed objective response rates and a manageable safety profile in patients with NF1-PN $SWTX, #SpringWorksTherapeutics, #SpringWorksTx, #SpringWorks https://t.co/AnwEoAYoZr
SpringWorks Therapeutics reveals long-term efficacy and safety data from the Phase 3 DeFi trial of nirogacestat in adults with progressing desmoid tumors $SWTX, #SpringWorksTherapeutics, #SpringWorksTx, #SpringWorks https://t.co/ZdkAsEWdK8
FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN $SWTX, #SpringWorksTherapeutics, #SpringWorksTx, #SpringWorks https://t.co/7V6wrPWCpf
SpringWorks Therapeutics Completes Submission of NDA to the FDA for Mirdametinib for the Treatment of Children and Adults with Neurofibromatosis Type 1- Associated Plexiform Neurofibromas (NF1-PN) $SWTX, #SpringWorksTx https://t.co/ivhTWKtn0L
SpringWorks Therapeutics Closes Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares $SWTX, #SpringWorksTherapeutics, #SpringWorksTx https://t.co/4TIWQHbSEi
SpringWorks Therapeutics Prices Upsized Public Offering of Common Stock $SWTX, #SpringWorksTx https://t.co/cdH44JiDJv
SpringWorks Therapeutics Announces FDA Approval of OGSIVEO (nirogacestat) as the First and Only Treatment for Adults with Desmoid Tumors $SWTX, #SpringWorksTherapeutics, #SpringWorksTx, #SpringWorks, #DesmoidTumor, #DesmoidTumors, #Tumor, #Cancer https://t.co/Wt0BmiGEaA
FDA Approves First Therapy for Rare Type of Non-Cancerous Tumors $SWTX, #SpringWorksTherapeutics, #SpringWorksTx, #SpringWorks, #Tumor, #Cancer https://t.co/cJiIJRfwfi
SpringWorks Therapeutics reveals positive topline results from the pivotal Phase 2b ReNeu trial evaluating mirdametinib in patients with neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN) $SWTX, #SpringWorksTherapeutics, #SpringWorksTx https://t.co/z3rTW7mu1n
Director, Commercial Operations
at SpringWorks Therapeutics
What you will do The Director Commercial Operations holds accountability for directing marketing...
#Operations #jobspresso #springworkstx
https://t.co/j7byiF8lXw
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.1M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
108.8M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.3M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.5M followers
KATY PERRY
@katyperry
86.8M followers
Taylor Swift
@taylorswift13
80.6M followers
Lady Gaga
@ladygaga
72.1M followers
Kim Kardashian
@kimkardashian
69.4M followers
YouTube
@youtube
68.6M followers
Virat Kohli
@imvkohli
68.5M followers
Bill Gates
@billgates
63.4M followers
The Ellen Show
@theellenshow
62.5M followers
CNN
@cnn
61.9M followers
Neymar Jr
@neymarjr
61M followers
X
@x
60.9M followers
CNN Breaking News
@cnnbrk
59.9M followers